Innovation Pharmaceuticals Inc (IPIX)

[RJFL]

Re: Dr. Daniel Jorgenson. In doing some researching about defensin mimetics today and what completion may be out there I came across a company called ioGenetics. They have a drug in development called IOG101 that is targeted towards ABSSSI like Brilicidin. Then I happen to see Dr. Jorgenson is listed as the Chief Medical Officer for them. I know Dr. Jorgenson presented Brilicidin data for Cellceutix at Therapeutic Area Partnership (TAP)last November so I had assumed he had joined Cellceutix since he headed up the research for "B" at Polymedix. I noted we don't list him on the Cellceutic "Our Team" page so is he just a consultant to Cellceutix with regards to Brilicidin? If so too bad I thought he was "on our team" so to speak.